ClinConnect ClinConnect Logo
Search / Trial NCT02735824

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

Launched by UNIVERSITY CHILDREN'S HOSPITAL, ZURICH · Apr 7, 2016

Trial Information

Current as of June 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating the genetic causes of primary immunodeficiency (PID), a condition where the immune system doesn't function properly. People with PID often experience frequent and severe infections or other health issues related to the immune system. The study aims to understand these genetic factors by comparing individuals suspected of having PID with healthy individuals. This research could help identify new genetic causes of immunodeficiencies and improve future treatments.

If you or someone you know has symptoms suggesting primary immunodeficiency, you may be eligible to participate in this study, which is open to patients, healthy relatives, and volunteers of all ages and genders. Participants will need to provide consent for their information to be used in the study. There are no specific exclusions, making it easier for many individuals to join. By participating, you could help advance our understanding of these immune system disorders, which may lead to better management and care for those affected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient with suspected PID, healthy relative or healthy volunteer
  • consent
  • Exclusion Criteria:
  • none

About University Children's Hospital, Zurich

The University Children's Hospital Zurich is a leading academic medical institution dedicated to advancing pediatric healthcare through innovative research and clinical excellence. Affiliated with the University of Zurich, the hospital specializes in a wide range of pediatric disciplines, offering comprehensive care to children and adolescents. As a prominent sponsor of clinical trials, the institution is committed to exploring new therapies and improving treatment protocols, ensuring that young patients benefit from the latest advancements in medicine. With a focus on collaboration, the hospital engages in partnerships with researchers, healthcare professionals, and pharmaceutical companies to drive impactful studies that enhance the health and well-being of children globally.

Locations

Zurich, Zh, Switzerland

Basel, , Switzerland

Patients applied

0 patients applied

Trial Officials

Jana M Pachlopnik Schmid, MD PhD

Principal Investigator

University Children's Hospital, Zurich

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials